Hearts and Minds Investments (HM1) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
The meeting was opened with a quorum present, welcoming both in-person and online shareholders, and introducing the board, executives, and auditors.
The hybrid format enabled broad participation, with clear instructions for questions and voting provided to all attendees.
Financial performance review
Portfolio increased by 11.7% for the year ended 30 June 2024, with a 32% return for the year to 31 October 2024 and a 10.7% annualized return since inception.
Share price rose from $2.26 to $2.58 over FY24, with total shareholder returns of 20% and the share price discount to NTA narrowing to 12%.
Technology holdings and the 2023 conference portfolio were key drivers of performance; Munro Partners' addition as a core manager had a positive impact.
Guzman y Gomez IPO delivered a 134% return since investment; Rokt pre-IPO position is held at cost.
Board and executive committee updates
Directors and key executives were introduced, with the board focused on sustaining investment performance and shareholder engagement.
Munro Partners joined as a new core fund manager, contributing to improved results.
Latest events from Hearts and Minds Investments
- FY24 saw an 11.7% portfolio return, 20% shareholder return, and increased fully franked dividends.HM1
H2 20249 Jun 2026 - FY25 saw a 25.5% portfolio return, higher dividends, and strong support for medical research.HM1
H2 20259 Jun 2026 - Half-year profit hit $115.3M, with strong returns and a higher dividend declared.HM1
H1 20255 Jun 2026 - Flat returns and a major write-down led to a sharp profit drop, but the interim dividend was raised.HM1
H1 20265 Jun 2026 - Strong returns, rising dividends, and major medical research funding highlighted at AGM.HM1
AGM 202526 Nov 2025